Last edition
News about "Onswik clinical trial results"
US FDA Approves Lilly's Onswik for Adults Living with T2D
The US FDA has approved Lilly’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with Type 2 Diabetes (T2D).
Onswik Clinical Trial Results | 25/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members